Clal Insurance Enterprises Holdings LTD has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $11.3 Billion distributed in 124 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Exchange Traded Fd Tr with a value of $1.24B, Spdr S&P 500 ETF Trust with a value of $1.01B, Vanguard Index Fds S&P 500 ETF with a value of $691M, Teva Pharmaceutical Industries LTD with a value of $621M, and Financial Sector Spdr with a value of $377M.

Examining the 13F form we can see an increase of $1.74B in the current position value, from $9.57B to 11.3B.

Clal Insurance Enterprises Holdings LTD is based out at Tel Aviv, L3

Below you can find more details about Clal Insurance Enterprises Holdings LTD portfolio as well as his latest detailed transactions.

Portfolio value $11.3 Billion
ETFs: $5.62 Billion
Technology: $2.55 Billion
Healthcare: $766 Million
Communication Services: $700 Million
Industrials: $356 Million
Consumer Cyclical: $301 Million
Utilities: $270 Million
Basic Materials: $253 Million
Other: $278 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 124
  • Current Value $11.3 Billion
  • Prior Value $9.57 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.